A Rigorously Simple Quantitative Model for Free Radical Behavior in Aerobic Biological Systems
Skin Pharmacology and Physiology · 2024
DOI: 10.1159/000542600 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Skin Pharmacology and Physiology, 2024. Verfasst von Leonhard Zastrow und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, Center of Experimental and Applied Cutaneous Physiology, Charité - Universitätsmedizin Berlin…. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Models, Biological. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 74 Literaturangaben.
Abstract (Originalsprache)
Background: Human life is based on oxygen respiration and an enzymatic, free radical-dependent water chemistry, whose billions of parallel reactions take place at pH ∼7.4 and a temperature of 37°C, in accordance with the laws of chemistry. The cellular metabolic processes occur over time periods covered by the half-lives of reactive oxygen species (ROS) for °OH to over 10 s for lipid oxygen species (LOS), indicating that mixtures of free radicals form the basic components for these processes. Summary: The main source of radicals is the mitochondrial conversion of 1–5% oxygen into “primary” ROS and “secondary” LOS. Every endogenous and exogenous radical generation, triggered by “natural background radiation,” “natural environment,” or “solar radiation” leads to qualitatively similar mixtures of “primary” ROS and “secondary” LOS or RNS (reactive nitrogen species). A Multilevel Antioxidant Regulation, Repair and Protection System (MARRPS) keeps these radical mixtures in a steady state. Depending on the total number of free radicals, different areas of radical action are defined. The Free Radical Ground State (FRGS) with “homeostasis” and “adaptive homeostasis,” the Free Radical Threshold Value (FRTV), and Free Radical Pathological Conditions (FRPC). The quantitative ratio ROS > LOS comprehensively characterizes the “'homeostasis” and “adaptive homeostasis” area of the FRGS. The total number of free radicals cannot be measured directly in the “homeostasis” area. “Adaptive homeostasis” is achieved when excess radicals are stable produced beyond “homeostasis” of the FRGS. The quantity that remains controllable in this range is a maximum of ∼3.58 × 1012 radicals/mg, the value of the body constant FRTV. The sensitized MARRPS provides “semi-stable homeostatic” states characterized by dual stability with ROS > LOS and a stable total ROS/LOS and RNS count beyond the basal FRGS “homeostasis.” If the total number of all radicals exceeds the FRTV, where LOS > ROS, this initiates uncontrolled radical chain reactions. The partial failure of the MARRPS in the FRPC area leads to pathological processes which are the starting point for a hundred different diseases. Key Messages: The universal body constant FRTV is the basis for all regular life processes. The design principle described by this simple model applies universally to all aerobic life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Allergology, Center of Experimental and Applied Cutaneous Physiology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universitä…
Zitieren
APA
Zastrow, L., Lademann, J., Meinke, M. C., & Lohan, S. B. (2024). A Rigorously Simple Quantitative Model for Free Radical Behavior in Aerobic Biological Systems. Skin Pharmacology and Physiology. https://doi.org/10.1159/000542600
Vancouver
Zastrow L, Lademann J, Meinke MC, Lohan SB. A Rigorously Simple Quantitative Model for Free Radical Behavior in Aerobic Biological Systems. Skin Pharmacology and Physiology. 2024. doi:10.1159/000542600
BibTeX
@article{Zastrow2024,
author = {Zastrow, Leonhard and Lademann, Jürgen and Meinke, Martina C and Lohan, Silke B},
title = {A Rigorously Simple Quantitative Model for Free Radical Behavior in Aerobic Biological Systems},
journal = {Skin Pharmacology and Physiology},
year = {2024},
doi = {10.1159/000542600}
}
EUVIMED